Innovation in
All We Do

For more than 30 years, Amgen has been at the forefront of modern biotechnology, inventing industry-leading technologies to develop and manufacture biologic medications for humans.1

By sharing methods and data,and offering expertise to others in the scientific community, Amgen has helped advance the field of biologic medications.2,3 We continue to be a leader in developing efficient and flexible processes with the goal of making high-quality, reliably supplied therapeutics.1 We are well positioned to develop and produce innovative biologic and biosimilar medications.1

References

  1. Data on file. Amgen.
  2. Swift R. Case study—glass vial delamination in a biopharmaceutical product. Paper presented at: Rx-360 Glass Delamination Scientific Symposium; May 25, 2011; Arlington, VA.
  3. Data on file. Amgen.

Innovation in providing biologic medications and industry-leading manufacturing processes.

Review Case Study